Why a Targeted Therapy Is Better Than Immunotherapy For Some Patients With Inoperable Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC), with an epidermal growth factor receptor (EGFR) mutation, tends not to respond well to immunotherapy treatments, including durvalumab. However, Yale Cancer Center (YCC) researchers recently reported in the Journal of Thoracic Oncology that the targeted therapy osimertinib, when administered after chemotherapy and radiation, is associated with significantly improved progression-free survival (living without the cancer worsening).

Cedars-Sinai President and CEO Thomas M. Priselac to Retire

Thomas M. Priselac, whose leadership over the last 30 years as Cedars-Sinai’s president and CEO significantly expanded the scope and quality of its clinical, educational, research and community benefit programs, has announced his plans to retire.

Expert Analysis: Black Americans Have Highest Cancer Mortality Rates In The United States

For Black History Month, Hackensack Meridian Health offers experts on some of the reasons behind higher cancer rates in the Black community and how to reverse the trends.

Pedestrian injuries from falls versus motor vehicle collisions: are we lacking critical policy and interventions?

Using Emergency Medical Services (EMS) data, researchers at Columbia University Mailman School of Public Health compared the national burden of pedestrian injuries from motor vehicles to that of pedestrian falls occurring on streets and sidewalks and found that the probability of a pedestrian suffering a severe injury is higher for motor vehicle collisions as compared to falls.

Surgeons’ choice of skin disinfectant impacts infection risk, Canadian-American study shows

Researchers of the PREPARE trial, which enrolled nearly 8,500 participants at 25 hospitals in Canada and the United States, found the use of iodine povacrylex in alcohol to disinfect a patient’s skin could prevent surgical site infection in thousands of patients undergoing surgery for a closed fracture each year.

Experts available to discuss potential harm to patients from AI-based software in doctor’s offices

In a new commentary published in the Journal of the American Medical Association (JAMA), University of Maryland School of Medicine faculty warn against the use of AI-driven software tools and other large language models to summarize patient medical data without…

Hackensack Meridian Neuroscience Institute At Jersey Shore University Medical Center Now Providing Extraordinary Treatment to Improve Stroke Survivors’ Mobility

Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center completed its first Paired VNS™ Therapy case with a stroke survivor who has yet to regain her desired hand and arm function after five years of traditional physical and occupational therapy.

The American Macular Degeneration Foundation Premieres Several New Short Films and Offers Free Resources During Age-related Macular Degeneration (AMD) and Low Vision Awareness Month

A 2024 AMD Awareness Month Resource Page, designed for the public and journalists, offers educational content, shareable talking points, fact sheets, shareable social media graphics, videos, opportunities for action, and more.

Dr. Gabe Xu wins $75K McMahon-Pleiad Prize from University of Alabama System in recognition of research contributions

Dr. Gabe Xu, an associate professor of mechanical and aerospace engineering in the College of Engineering at The University of Alabama in Huntsville (UAH), has been selected to receive the 2023 University of Alabama (UA) System McMahon-Pleiad Prize.

Podcast: Down to Business Episode 101 – Robert Isom, CEO of American Airlines

On this inaugural episode of the Down to Business podcast, host Sharon F. Matusik, Edward J. Frey Dean of the Ross School of Business, is joined by Robert Isom, MBA ’91, to discuss his path to Michigan Ross, his career as a Ross MBA, his journey to becoming CEO and president of American Airlines, and his advice for current and prospective Ross students who are interested in leadership careers.

RNA Scientist Receives Federal Funding to Commercialize Molecular Tool Against Alzheimer’s Disease

University at Albany scientist Scott Tenenbaum, founder of UAlbany spinoff company sxRNA Technologies, Inc. (sxRNA Tech), has received $500,000 from the National Institute on Aging, part of the National Institutes of Health, to study how aging brain cells shape the progression of Alzheimer’s disease, and advance RNA technology that could inform new therapeutics to prevent and treat Alzheimer’s and related dementias.

Scientists Reveal How Tar Particles from Wildfire Smoke Absorb and Refract Solar Radiation, Light in Atmosphere

A multi-institutional team of researchers studied how solar radiation from the sun interacts with individual tar balls. This research, featured on the cover of ACS Publications’ Environmental Science & Technology, provides insights into how wildfires influence climate change.

وضع خريطة لسلوكيات خلايا الورم الدِبقي عالي الدرجة لتحسين العلاج

الأورام الدبقية عالية الدرجة هي أورام سرطانية تنتشر بسرعة في الدماغ أو الحبل النخاعي. في دراسة جديدة أجريت تحت إشراف مايو كلينك، وجد الباحثون أن هوامش أورام الدماغ الغزوية للورم الدبقي عالي الدرجة تحتوي على تغيرات جينية وجزيئية مميزة بيولوجيًا تشير إلى السلوك العدواني وتكرار المرض. وتُظهر النتائج تصورات متعمقة للعلاجات المحتملة التي يمكن أن تحوّل مسار المرض.